Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Malaghan Institute for InfoPages here.
Malaghan Institute - Latest News [Page 1]
Dame Patsy Reddy, Sir Ashley Bloomfield And David Downs Appointed To Malaghan Institute Trust Board
Thursday, 17 October 2024, 9:28 am | Malaghan Institute
Chair Sir Paul Collins announced the appointments in the institute’s annual report, published today, acknowledging recent changes and future-proofing of the institute had necessitated a careful review of the skills required to strengthen and sustain its governance team. More >>
New Clinical Research Aims To Reduce Stomach Cancer Rates And Disparities In New Zealand
Tuesday, 28 May 2024, 10:36 am | Malaghan Institute
H. pylori is responsible for most stomach cancers in New Zealand. Usually contracted in childhood, H. pylori infects the cells of the stomach, causing gastritis, or inflammation of the stomach lining. More >>
NZ Invention To Enhance Safety Of CAR T And Other Cell Therapies
Monday, 29 January 2024, 12:08 pm | Malaghan Institute
An innovative 'safety switch' for CAR T-cell therapy, designed at the Malaghan Institute and recently patented, has the potential to significantly enhance the safety and accessibility of this cutting-edge cancer immunotherapy and other cell therapies. ... More >>
Philanthropic Partnership Sees Record $15 Million Boost To Biomedical Research
Tuesday, 12 December 2023, 5:52 pm | Malaghan Institute
Research into cancer, infectious disease and allergic and inflammatory conditions is set to enter new frontiers thanks to one of the biggest ever private gifts to biomedical research in New Zealand. On the back of more than 12 years of investment, ... More >>
Scientific Breakthrough Harnesses mRNA Technology To Develop Powerful Malaria Vaccine
Friday, 21 July 2023, 7:04 am | Malaghan Institute
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization, yet has no effective long-lasting vaccine. Trans-Tasman ... More >>
Investment In Science Will Boost New Zealand’s Resilience And Prosperity
Thursday, 18 May 2023, 3:45 pm | Malaghan Institute
The Malaghan Institute is welcoming today’s budget announcement of more than $450M in New Zealand science and innovation. “The investment recognises the value that research, science and innovation brings to our nation’s resilience and prosperity,” ... More >>
Kiwi-made Covid-19 Booster Vaccine Offers 100% Protection In Preclinical Study
Friday, 3 March 2023, 12:14 pm | Malaghan Institute
A preclinical study evaluating a Kiwi-made Covid-19 vaccine – Kiwi Vax – has shown its unique formulation induces a safe and highly effective immune response to SARS-CoV-2 variants of concern, making it a promising booster vaccine candidate. ... More >>
Clinical Study Investigating The Impact Of Dietary Fibre On Type-2 Diabetes
Tuesday, 20 September 2022, 5:27 pm | Malaghan Institute
A clinical study is investigating the effects of increased dietary fibre on immune cell function and blood sugar levels for people living with type-2 diabetes, with the aim of offering insight into better ways of managing the disease. “We’re ... More >>
Inaugural Te Urungi Fellowship Awarded To Dr Theresa Pankhurst
Tuesday, 26 April 2022, 4:20 pm | Malaghan Institute
Dr Theresa Pankhurst A new fellowship to strengthen relationships between the Malaghan Institute and Māori communities and ultimately improve health outcomes for Māori has been awarded to postdoctoral researcher Dr Theresa Pankhurst (Ngāi Tahu, Ngāti ... More >>
Clinical Study Shows Strong Immune Response To Pfizer Vaccine Across New Zealanders
Friday, 8 April 2022, 6:20 am | Malaghan Institute
A clinical study investigating immune responses to the Pfizer vaccine in New Zealanders at risk for COVID-19 disease has provided reassuring results says Dr Fran Priddy, the Executive Director of Vaccine Alliance Aotearoa New Zealand – Ohu Kaupare Huaketo ... More >>
Nanoparticle Tech Paves Way For Home-grown Vaccines And Therapeutics
Thursday, 27 January 2022, 6:27 pm | Malaghan Institute
New Zealand’s ability to make its own mRNA vaccines like the Pfizer COVID-19 vaccine is a step closer with the arrival of cutting-edge nanoparticle technology, the first of its kind in New Zealand. The NanoAssemblr Blaze is designed to produce lipid nanoparticles ... More >>
New Study Opens Doors For Immunotherapies For Prostate Cancer
Monday, 13 December 2021, 11:17 am | Malaghan Institute
Recent research from the Malaghan Institute has uncovered a new way prostate cancer could be targeted by immunotherapies. The study, funded by the Prostate Cancer Foundation and published in Frontiers in Immunology , found that immune cells that can reside ... More >>
Discovery Points To The Skin As ‘ground Zero’ For Allergic Disease
Friday, 19 November 2021, 9:07 am | Malaghan Institute
A ground-breaking discovery from the Malaghan Institute has shone a light on immune cells in the skin, suggesting they play a much larger role in the onset of allergies than first thought. The Immune Cell Biology team The discovery throws into question ... More >>
Study Finds A High-fibre Diet Can Improve Immune Response To Vaccines
Thursday, 18 November 2021, 1:25 pm | Malaghan Institute
A study from the Malaghan Institute of Medical Research has found that a high fibre diet can improve the immune response to the first dose of a vaccine. Published in Frontiers in Immunology , the finding has implications for how we might tailor our ... More >>
New Partnership To Scale Up CAR T-cell Cancer Treatment In New Zealand
Thursday, 23 September 2021, 10:59 am | Malaghan Institute
A new partnership to scale up ground-breaking CAR T-cell cancer therapy in New Zealand has been announced today at the Malaghan Institute of Medical Research, with the arrival of state-of-the-art automated cell therapy manufacturing technology. BioOra, ... More >>
New Study Into Pfizer-BioNTech COVID-19 Vaccine To Provide Unique NZ Data
Thursday, 10 June 2021, 11:59 am | Malaghan Institute
A clinical study getting underway in Rotorua and Christchurch will provide valuable information on how our unique population responds to the Pfizer-BioNTech COVID-19 vaccine. The study, ‘Ka Mātau, Ka Ora' (from knowledge comes wellbeing), is being ... More >>
Vaccine Alliance Formed As Collaborators Establish National COVID-19 Vaccine Screening Programme
Thursday, 27 August 2020, 10:00 am | Malaghan Institute
The Malaghan Institute of Medical Research, University of Otago and Victoria University of Wellington will help lead efforts to secure a COVID-19 vaccine for New Zealand as part of the newly established Vaccine Alliance Aotearoa New Zealand – Ohu Kaupare ... More >>
Government Investment In National COVID-19 Vaccine Strategy Welcomed
Tuesday, 26 May 2020, 2:04 pm | Malaghan Institute
The Government’s investment in a national COVID-19 vaccine programme is the shot in the arm the country needs for its economic future and the health of its people says Director of the Malaghan Institute Professor Graham Le Gros. Research, Science ... More >>
Top Scientists Call For Urgent COVID Vaccine Strategy To Ensure NZ’s Health And Economic Viability
Tuesday, 14 April 2020, 7:01 pm | Malaghan Institute
Some of New Zealand’s top scientists are urging the need for a national COVID-19 vaccine programme to ensure New Zealand is best placed to access an effective vaccine at the earliest opportunity. Malaghan Institute Director Professor Graham Le Gros ... More >>
NZ’s first CAR T-cell cancer therapy clinical trial underway
Monday, 30 September 2019, 8:23 am | Malaghan Institute
New Zealand’s first clinical trial of CAR T-cell therapy, a revolutionary new approach to fighting cancer, is getting underway after receiving final regulatory approval. The phase I safety trial, called ENABLE, is part the of the Malaghan Institute’s ... More >>
